The anemia of chronic renal failure: pathophysiology and effects of recombinant erythropoietin.

[1]  F. Takaku,et al.  Response of uraemic bone marrow cells to erythropoietin in vitro. , 2009, Scandinavian journal of haematology.

[2]  J. Adamson,et al.  The Use of Recombinant Erythropoietin in the Treatment of the Anemia of Chronic Renal Failure a , 1989, Annals of the New York Academy of Sciences.

[3]  G. Mayer,et al.  Working capacity is increased following recombinant human erythropoietin treatment. , 1988, Kidney international.

[4]  J. Adamson,et al.  The anemia of end-stage renal disease: hematopoietic progenitor cell response. , 1988, Kidney international.

[5]  J. Adamson,et al.  Recombinant human erythropoietin: implications for nephrology. , 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  J. Ward,et al.  Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody. , 1988, The New England journal of medicine.

[7]  F. Wendling,et al.  Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney. , 1988, The Journal of clinical investigation.

[8]  M. Koury,et al.  Localization of erythropoietin synthesizing cells in murine kidneys by in situ hybridization. , 1988, Blood.

[9]  C. Ponticelli,et al.  Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis. , 1987, British medical journal.

[10]  R. Hakim,et al.  Iron overload and mobilization in long-term hemodialysis patients. , 1987, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  G. Stamatoyannopoulos,et al.  Stimulation of fetal hemoglobin synthesis by erythropoietin in baboons. , 1987, The New England journal of medicine.

[12]  M. Sawka,et al.  Erythrocyte reinfusion and maximal aerobic power. An examination of modifying factors. , 1987, JAMA.

[13]  R. Swartz,et al.  Microcytic anemia in dialysis patients: reversible marker of aluminum toxicity. , 1987, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  J. Adamson,et al.  Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. , 1987, The New England journal of medicine.

[15]  C. Winearls,et al.  EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSIS , 1986, The Lancet.

[16]  K. Aoki,et al.  Characterization and biological effects of recombinant human erythropoietin. , 1986, Immunobiology.

[17]  J. Adamson,et al.  Human erythropoietin gene: high level expression in stably transfected mammalian cells and chromosome localization. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Adamson,et al.  Hematopoietic inhibitors in chronic renal failure: lack of in vitro specificity. , 1986, Kidney international.

[19]  C. H. Lin,et al.  Cloning and expression of the human erythropoietin gene. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Adamson,et al.  Anemia of end-stage renal disease (ESRD). , 1985, Kidney international.

[21]  J. Adamson,et al.  Erythropoietin kinetics in normal and uremic sheep. , 1985, The Journal of laboratory and clinical medicine.

[22]  J. Adamson,et al.  The anaemia of chronic renal failure in sheep: studies in vitro , 1984, British journal of haematology.

[23]  J. Adamson,et al.  The anemia of chronic renal failure in sheep. Response to erythropoietin-rich plasma in vivo. , 1984, The Journal of clinical investigation.

[24]  J. Caro,et al.  Biologic and immunologic erythropoietin in extracts from hypoxic whole rat kidneys and in their glomerular and tubular fractions. , 1984, The Journal of laboratory and clinical medicine.

[25]  R. McGonigle,et al.  Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency. , 1984, Kidney international.

[26]  R. McGonigle,et al.  Hemodialysis and continuous ambulatory peritoneal dialysis effects on erythropoiesis in renal failure. , 1984, Kidney international.

[27]  T. Hawkins,et al.  IS ANAEMIA DURING CONTINUOUS AMBULATORY PERITONEAL DIALYSIS REALLY BETTER THAN DURING HAEMODIALYSIS? , 1983, The Lancet.

[28]  N. Lameire,et al.  Influence of continuous ambulatory peritoneal dialysis on the anemia of endstage renal disease. , 1983, Kidney international.

[29]  H. Marti,et al.  Red cell survival and red cell enzymes in patients on continuous peritoneal dialysis (CAPD). , 1983, Clinical nephrology.

[30]  M. Freedman,et al.  Ribonuclease inhibition of erythropoiesis in anemia of uremia. , 1983, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[31]  G. Remuzzi,et al.  URAEMIC BLEEDING: ROLE OF ANAEMIA AND BENEFICIAL EFFECT OF RED CELL TRANSFUSIONS , 1982, The Lancet.

[32]  Cotes Pm.  Immunoreactive erythropoietin in serum. I. Evidence for the validity of the assay method and the physiological relevance of estimates. , 1982 .

[33]  B. Delano,et al.  Absence of Anemia in Maintenance Hemodialysis , 1981, The International journal of artificial organs.

[34]  E. Ritz,et al.  Silicone-induced splenomegaly: treatment of pancytopenia by splenectomy in a patient on hemodialysis. , 1981, The New England journal of medicine.

[35]  J. Fisher,et al.  Identification of spermine as an inhibitor of erythropoiesis in patients with chronic renal failure. , 1981, The Journal of clinical investigation.

[36]  J. Cunningham,et al.  Do patients receiving haemodialysis need folic acid supplements? , 1981, British medical journal.

[37]  M. Neff,et al.  A comparison of androgens for anemia in patients on hemodialysis. , 1981, The New England journal of medicine.

[38]  R. Gleason,et al.  Clinical consequences of acquired transfusional iron overload in adults. , 1981, The New England journal of medicine.

[39]  R. R. Robinson,et al.  Physical activity and employment status of patients on maintenance dialysis. , 1981, The New England journal of medicine.

[40]  Wallner Sf,et al.  Evidence that inhibition of erythropoiesis is important in the anemia of chronic renal failure. , 1981 .

[41]  D. Deykin,et al.  Treatment of the bleeding tendency in uremia with cryoprecipitate. , 1980, The New England journal of medicine.

[42]  E. Cronkite,et al.  Radioimmunoassay of erythropoietin: circulating levels in normal and polycythemic human beings. , 1980, The Journal of laboratory and clinical medicine.

[43]  A. Huang,et al.  Inhibitor of marrow thymidine incorporation from sera of patients with uremia. , 1980, Kidney international.

[44]  J. Winchester,et al.  IRON-OVERLOAD-ASSOCIATED MYOPATHY IN PATIENTS ON MAINTENANCE HÆMODIALYSIS: A HISTOCOMPATIBILITY-LINKED DISORDER , 1980, The Lancet.

[45]  R. Hamstra,et al.  Intravenous iron dextran in clinical medicine. , 1980, JAMA.

[46]  G. Remuzzi,et al.  Bleeding in renal failure: a possible role of vascular prostacyclin (PGI2). , 1979, Clinical nephrology.

[47]  G. Barbour.  Effect of parathyroidectomy on anemia in chronic renal failure. , 1979, Archives of internal medicine.

[48]  E. Goldwasser,et al.  Radioimmunoassay of erythropoietin. , 1979, Blood cells.

[49]  J. Caro,et al.  Erythropoietin levels in uremic nephric and anephric patients. , 1979, The Journal of laboratory and clinical medicine.

[50]  D. Cattran,et al.  A controlled trial of nondrolone decanoate in the treatment of uremic anemia. , 1977, Kidney international.

[51]  J. Cook,et al.  Iron balance in hemodialysis patients. , 1977, Annals of internal medicine.

[52]  S. Weinberg,et al.  Myelofibrosis and renal osteodystrophy. , 1977, The American journal of medicine.

[53]  E. Goldwasser,et al.  Purification of human erythropoietin. , 1977, The Journal of biological chemistry.

[54]  J. Bergström,et al.  Hypersequestration of 51Cr-labelled erythrocytes as a criterion for splenectomy in regular hemodialysis patients. , 1977, Clinical nephrology.

[55]  J. Eschbach,et al.  14C cyanate as a tag for red cell survival in normal and uremic man. , 1977, The Journal of laboratory and clinical medicine.

[56]  G. Pampiglione,et al.  INFANTILE SPASMS AND SUBSEQUENT APPEARANCE OF TUBEROUS SCLEROSIS SYNDROME , 1975, The Lancet.

[57]  F. Mcdermott,et al.  Inhibition of Cell Proliferation in Renal Failure and its Significance to the Uraemic Syndrome: A Review , 1975, Scottish medical journal.

[58]  M. Worwood,et al.  Ferritin in serum. Clinical and biochemical implications. , 1975, The New England journal of medicine.

[59]  U. Binswanger,et al.  Oxidative injury to erythrocytes, cell rigidity, and splenic hemolysis in hemodialyzed uremic patients. , 1975, Annals of internal medicine.

[60]  R. Longnecker,et al.  Controlled study of androgen therapy in anemia of patients on maintenance hemodialysis. , 1974, The New England journal of medicine.

[61]  J. Adamson,et al.  Improvement in the anemia of chronic renal failure with fluoxymesterone. , 1973, Annals of internal medicine.

[62]  W. Fried.  The liver as a source of extrarenal erythropoietin production. , 1972, Blood.

[63]  L. Harker,et al.  The bleeding time as a screening test for evaluation of platelet function. , 1972, The New England journal of medicine.

[64]  M. Neff.  Hemodynamics of Uremic Anemia: The author replies , 1972 .

[65]  M. Innis,et al.  SPLENECTOMY FOR ANÆMIA IN PATIENTS ON REGULAR HÆMODIALYSIS , 1971 .

[66]  M. Neff,et al.  Hemodynamics of Uremic Anemia , 1971, Circulation.

[67]  H. Horowitz.  Uremic toxins and platelet function. , 1970, Archives of internal medicine.

[68]  J. Adamson,et al.  Disorders of red blood cell production in uremia. , 1970, Archives of internal medicine.

[69]  R. Degowin,et al.  Erythropoiesis and erythropoietin in patients with chronic renal failure treated with hemodialysis and testosterone. , 1970, Annals of internal medicine.

[70]  J. Cook,et al.  Iron absorption in chronic renal disease. , 1970, Clinical science.

[71]  J. Adamson,et al.  The erythropoietin-hematocrit relationship in normal and polycythemic man: implications of marrow regulation. , 1968, Blood.

[72]  J. Adamson,et al.  The kidney and erythropoiesis. , 1968, The American journal of medicine.

[73]  A. Shaw,et al.  Reticulocytosis in renal failure. , 1967, Lancet.

[74]  J. Adamson,et al.  Erythropoiesis in patients with renal failure undergoing chronic dialysis. , 1967, The New England journal of medicine.

[75]  P. Castaldi,et al.  The bleeding disorder of uraemia. A qualitative platelet defect. , 1966, Lancet.

[76]  R. Brown.  Plasma erythropoietin in chronic uraemia. , 1965, British medical journal.

[77]  J. Contrera,et al.  EXTRACTION OF ERYTHROPOIETIN FROM KIDNEYS OF HYPOXIC AND PHENYLHYDRAZINE-TREATED RATS. , 1965, Blood.

[78]  D. Nathan,et al.  ERYTHROPOIESIS IN ANEPHRIC MAN. , 1964, The Journal of clinical investigation.

[79]  B. Lewartowski,et al.  CHEMICAL AND BIOLOGIC PROPERTIES OF AN ERYTHROPOIETIN-GENERATING SUBSTANCE OBTAINED FROM PERFUSATES OF ISOLATED ANOXIC KIDNEYS. , 1964, The Journal of laboratory and clinical medicine.

[80]  Naets Jp,et al.  Measurement of erythropoietic stimulating factor in anemic patients with or without renal disease. , 1962 .

[81]  W. Aherne.  The “Burr” Red Cell and Azotaemia , 1957, Journal of clinical pathology.

[82]  E. Goldwasser,et al.  Role of the Kidney in Erythropoiesis , 1957, Nature.

[83]  J. H. Ferguson,et al.  Bleeding tendency in uremia. , 1956, Blood.

[84]  Joske Ra,et al.  Isotope investigations of red cell production and destruction in chronic renal disease. , 1956 .

[85]  Markson Jl,et al.  The anaemia of chronic renal insufficiency; the effect of serum from azotaemic patients on the maturation of normoblasts in suspension cultures. , 1956 .

[86]  P. Mollison,et al.  Red cell life-span in nephritis and in hepatic cirrhosis. , 1953, Clinical science.

[87]  A. Erslev,et al.  Humoral regulation of red cell production. , 1953, Blood.

[88]  P. Bruneval,et al.  Identification of tissues and cells producing erythropoietin in the anemic mouse. , 1988, Contributions to nephrology.

[89]  K. Braumann,et al.  Effect of erythropoietin treatment on O2 affinity and performance in patients with renal anemia. , 1988, Contributions to nephrology.

[90]  J. Bahlmann,et al.  Effect of treatment with recombinant human erythropoietin on peripheral hemodynamics and oxygenation. , 1988, Contributions to nephrology.

[91]  M. Brandis,et al.  Treatment of a seven-year-old child with end-stage renal disease and hemosiderosis by recombinant human erythropoietin. , 1988, Contributions to nephrology.

[92]  J. Adamson,et al.  Spermine and spermidine are non-specific inhibitors of in vitro hematopoiesis. , 1987, Kidney international.

[93]  E. Ritz,et al.  Recombinant human erythropoietin therapy in haemodialysis patients--dose determination and clinical experience. , 1987, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[94]  J. Egrie,et al.  Erythropoietin: gene cloning, protein structure, and biological properties. , 1986, Cold Spring Harbor symposia on quantitative biology.

[95]  E. Fritsch,et al.  Isolation and characterization of genomic and cDNA clones of human erythropoietin , 1985, Nature.

[96]  J. Egrie,et al.  Characterization of recombinant monkey and human erythropoietin. , 1985, Progress in clinical and biological research.

[97]  J. Eschbach.  Iron kinetics in healthy individuals and in chronic renal insufficiency. , 1984, Contributions to nephrology.

[98]  D. P. Bentley,et al.  Anaemia of chronic renal failure. Polyamines are not raised in uraemic serum. , 1984, Nephron.

[99]  J. Adamson,et al.  High levels of the circulating form of parathyroid hormone do not inhibit in vitro erythropoiesis. , 1983, The Journal of laboratory and clinical medicine.

[100]  Jimmy D Bell,et al.  Changes in red cell mass, plasma volume and hematocrit in patients on CAPD. , 1983, Transactions - American Society for Artificial Internal Organs.

[101]  J. Caro,et al.  Normalization of hematocrit in patients with end-stage renal disease on continuous ambulatory peritoneal dialysis: the role of erythropoietin. , 1982, The American journal of medicine.

[102]  I. Cobden,et al.  初期食道静脈りゅう治療におけるテルイプレシン(グリプレシン)とバソプレシンの比較試験 , 1982 .

[103]  G. Porter.  Changing of the Guard at NIH , 1982 .

[104]  J. Fisher.  Mechanism of the anemia of chronic renal failure. , 1980, Nephron.

[105]  A. Prasad,et al.  Abnormal plasma and erythrocyte zinc distribution in uremia. , 1978, Transactions - American Society for Artificial Internal Organs.

[106]  U. Essers,et al.  Effect of erythropoietin in normal men and in patients with renal insufficiency. , 1975, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.

[107]  R. Riggio,et al.  Clinical effects of bilateral nephrectomy. , 1975, The American journal of medicine.

[108]  K. Koch,et al.  Anemia of the regular hemodialysis patient and its treatment. , 1974, Nephron.

[109]  C. Blagg,et al.  The effects of erythrocyte mass transfer rates on solute clearance measurements during haemodialysis. , 1972, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.

[110]  T. Berne,et al.  Hypersplenism in the Uremic Hemodialyzed Patient , 1972 .

[111]  H. Marti,et al.  Red cell metabolism and haemolysis in patients on dialysis. , 1972, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.

[112]  C. Moore,et al.  Characterization of the anemia associated with chronic renal insufficiency. , 1958, The American journal of medicine.

[113]  I. R. Callen,et al.  Blood and bone marrow studies in renal disease. , 1950, American journal of clinical pathology.